Acta Psychiatrica Scandinavica

Cover image for Acta Psychiatrica Scandinavica

April 1990

Volume 82, Issue S358

Pages 3–188

  1. Original Article

    1. Top of page
    2. Original Article
    3. The search for new antipsychotic drugs
    4. Human pharmacokinetics and pharmacodynamics of antipsychotic drugs
    5. Dosage strategies of antipsychotic drugs
    6. Clinical profiles of antipsychotic drugs
    7. Long term treatment with antipsychotic drugs
    1. Introduction (page 3)

      Göran Sedvall

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05278.x

  2. The search for new antipsychotic drugs

    1. Top of page
    2. Original Article
    3. The search for new antipsychotic drugs
    4. Human pharmacokinetics and pharmacodynamics of antipsychotic drugs
    5. Dosage strategies of antipsychotic drugs
    6. Clinical profiles of antipsychotic drugs
    7. Long term treatment with antipsychotic drugs
    1. Monoamines and schizophrenia (pages 7–13)

      Göran Sedvall

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05279.x

    2. Neuropharmacological and behavioural properties of remoxipride in the rat (pages 21–26)

      S-O Ögren, L. FIoryall, H. Hall, O. Magnusson and K. Ängeby-Möller

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05281.x

    3. Biochemical pharmacology of the atypical neuroleptic remoxipride (pages 27–36)

      C. Köhler, H. Hall, O. Magnusson, T. Lewander and K. Gustafsson

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05282.x

  3. Human pharmacokinetics and pharmacodynamics of antipsychotic drugs

    1. Top of page
    2. Original Article
    3. The search for new antipsychotic drugs
    4. Human pharmacokinetics and pharmacodynamics of antipsychotic drugs
    5. Dosage strategies of antipsychotic drugs
    6. Clinical profiles of antipsychotic drugs
    7. Long term treatment with antipsychotic drugs
    1. Pharmacokinetics of antipsychotic drugs in man (pages 37–40)

      S. G. Dahl

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05283.x

    2. Clinical pharmacokinetics of remoxipride (pages 41–44)

      C. von Bahr, G. Movin, W.-A. Yisak, K.-G. Jostell and M. Widman

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05284.x

    3. Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms (pages 48–50)

      K.-G. Jostell, Y. D. Lapierre and the Canadian Remoxipride Study Group

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05286.x

    4. Tolerability and pharmacokinetics of remoxipride after intramuscular administration (pages 51–53)

      J.-P. Kahn, W. Yisak, C. Albaret, L. Nilsson, A. Zaar-Hedin and M. Laxenaire

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05287.x

    5. Cognitive disturbances in neuroleptic therapy (pages 56–57)

      W. H. Strauss and E. Klieser

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05289.x

    6. Drug interaction studies with remoxipride (pages 58–62)

      W. Yisak, C von Bahr, L. Farde, M. Grind, M. Mattila and S. Ogenstad

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05290.x

  4. Dosage strategies of antipsychotic drugs

    1. Top of page
    2. Original Article
    3. The search for new antipsychotic drugs
    4. Human pharmacokinetics and pharmacodynamics of antipsychotic drugs
    5. Dosage strategies of antipsychotic drugs
    6. Clinical profiles of antipsychotic drugs
    7. Long term treatment with antipsychotic drugs
    1. Guidelines for the dosage of antipsychotic drugs (pages 63–66)

      H. Beckmann and G. Laux

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05291.x

    2. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia - a Canadian multicentre trial (pages 72–77)

      Y. D. Lapierre, N. P. V. Nair, G. Chouinard, A. G. Awad, B. Saxena, B. Jones, D. J. McClure, D. Bakish, P. Max, R. Manchanda, P. Beaudry, D. BIoom, E. Rotstein, R. Ancill, P. Sandor, N. Sladen-Dew, C. Durand, R. Chandrasena, E. Horn, D. Elliot, M. Das, A. Ravindran and G. Matsos

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05293.x

    3. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol (pages 78–82)

      M. Patris, P. Agussol, J. M. Alby, S. Brion, G. Burnat, D. Castelnau, S. Deluermoz, H. Dufour, M. Ferreri, M. Goudemand, D. Leguay, T. Lamperiere, A. Martin, D. Morin, J. Tignol, T. Vincent and C. Albaret

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05294.x

  5. Clinical profiles of antipsychotic drugs

    1. Top of page
    2. Original Article
    3. The search for new antipsychotic drugs
    4. Human pharmacokinetics and pharmacodynamics of antipsychotic drugs
    5. Dosage strategies of antipsychotic drugs
    6. Clinical profiles of antipsychotic drugs
    7. Long term treatment with antipsychotic drugs
    1. The neuroleptics: a historical survey (pages 83–87)

      P Deniker

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05295.x

    2. Clinically relevant differences between antipsychotic compounds (pages 88–91)

      Trevor Silverstone

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05296.x

    3. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study. (pages 99–103)

      U. G. Ahlfors, R. Rimõn, B. Appelberg, U. Hagert, P. Harma, H. Katila, A. Mah-lanen, O-P. Mehtonen, H. Naukkarinen, J. Outakoski, H. Rantanen, A. Sorri, T. Tamminen, E. Tolvanen and A.-C. Holm

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05298.x

    4. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia (pages 104–107)

      J. Andersen, A. Kørner, P. Øsstergaard, C. Fensbo, M. Birket-Smith, S. Thiesen, N. R. Hansen, M. Fogh, M Kristensen, E. M. Møller-Nielsen, B. Jensen and N. Bjørum

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05299.x

    5. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia. (pages 108–110)

      J. A. den Boer, D. P. Ravelli, J. Huisman, J. Ohrvik, W. M. A. Verhoeven and H. G. M. Westenberg

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05300.x

    6. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison (pages 120–124)

      R. Deo, S. Soni, S. C. Rastogi, S. Levine, I. PIant, J. Guy Edwards, M. Mitchell and A. Chanas

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05302.x

    7. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia (pages 125–129)

      G. Laux, E. KIieser, H. G. Schröder, V. Dittmann, B. Unterweger, H. Schutert, P. König, H. W. Schöny, J. Bunse and H. Beckmann

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05303.x

    8. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia (pages 130–135)

      L. H. Lindström, I.-M. Wiesekjren, G. Struwe, E. Kristjansson, S. Akselsorn, H. Arthur, T. Andersen, S. Lindgren, Q. Norman, L. Naimell and G. Stening

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05304.x

    9. A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia (pages 136–137)

      R. G. McCreadie, N. Todd, M. Livingston, D. Eccleston, J. A. G. Watt, R. N. Herrington, D. Tait, G. Crocket, M. J. Mitchell and B. Huitfeldf

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05305.x

    10. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders (pages 138–141)

      J. Mendlewicz, E. de Bleeker, P. Cosyns, G. Deleu, F. Lotstra, A. Masson, C. Mertens, M. Parent, J. Peuskens, E. Suy, J. de Wilde, J. Wilmotte and J. Nörgard

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05306.x

    11. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia (pages 142–146)

      B. Pflug, M. Bartels, H. Bauer, J. Bunse, B. Gallhofer, S. Haas, W. T. H. Kanzow, E. Klieser, B. Küfferle, D. Stein, K. A. Steinberger and G. Weiselmann

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05307.x

    12. Panel discussion (pages 147–150)

      Chairman: T Silverstone

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05308.x

  6. Long term treatment with antipsychotic drugs

    1. Top of page
    2. Original Article
    3. The search for new antipsychotic drugs
    4. Human pharmacokinetics and pharmacodynamics of antipsychotic drugs
    5. Dosage strategies of antipsychotic drugs
    6. Clinical profiles of antipsychotic drugs
    7. Long term treatment with antipsychotic drugs
    1. Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride (pages 164–169)

      D. Morrison, A. Englund, V. Lawrie, T. Lewander, A. Schlachet and S.-E. Westerbergh

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05311.x

    2. Antipsychotics in the elderly (pages 170–175)

      Jules Rosen, Scott Bohon and Samuel Gershon

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05312.x

    3. Pharmacokinetics of remoxipride in elderly psychotic patients (pages 176–180)

      G. Movin, L. Gustafson, G. Franzén, E. Widerlöv, S. D. Soni, D. Tench, T. Nilsson and W. Yisak

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05313.x

    4. Remoxipride versus thioridazine in elderly psychotic patients (pages 181–185)

      A. L. Phanjoo and C. Link

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05314.x

    5. Closing remarks (pages 186–188)

      B J Carroll

      Version of Record online: 23 AUG 2007 | DOI: 10.1111/j.1600-0447.1990.tb05315.x

SEARCH

SEARCH BY CITATION